Institutional Ownership
Cue Biopharma Inc
CUSIP 22978P106COMCUEQ1 2026
13D / 13G Filings
24
Schedule 13D/13G on record
Beneficial Filers
9
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
51
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
24 filings · latest May 16, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | May 16, 2025 | Mark E. Strome | 13G/A | 5.0% | 2.17M | SEC |
| 2 | Mar 21, 2025 | Bleichroeder LP | 13G/A | 10.0% | 6.13M | SEC |
| 3 | Feb 14, 2025 | Slate Path Capital LP | 13G/A | 1.4% | 918.8K | SEC |
| 4 | Oct 7, 2024 | Bleichroeder LP | 13G/A | 10.0% | 6.13M | SEC |
| 5 | Mar 11, 2024 | Bleichroeder LP | 13G | 6.1% | 2.76M | SEC |
| 6 | Feb 7, 2024 | Blackrock Inc. | 13G | 5.0% | 2.25M | SEC |
| 7 | Jan 31, 2024 | Blackrock Inc. | 13G | 5.2% | 2.34M | SEC |
| 8 | Feb 14, 2023 | Slate Path Capital LP | 13G | 5.6% | 2.40M | SEC |
| 9 | Feb 3, 2023 | State Street Corp | 13G/A | 0.3% | — | SEC |
| 10 | Dec 2, 2022 | Nantahala Capital Management, LLC | 13G/A | 0.3% | 93.3K | SEC |
14 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Cue Biopharma Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bleichroeder LP | 6.82M | $1.57M |
| 2 | Gc Wealth Management Ria, LLC | 4.63M | $1.06M |
| 3 | Lion Point Capital, LP | 2.20M | $506.4K |
| 4 | Geode Capital Management, LLC | 1.06M | $244.8K |
| 5 | Robertson Stephens Wealth Management, LLC | 478.5K | $110.0K |
| 6 | Blackrock, Inc. | 449.2K | $103.3K |
| 7 | Texas Capital Bank Wealth Management Services Inc | 397.4K | $91.4K |
| 8 | Angeles Wealth Management, LLC | 310.0K | $71.3K |
| 9 | Advisory Research Inc | 257.2K | $59.1K |
| 10 | Stifel Financial Corp | 246.6K | $56.7K |